BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2019
View Archived Issues
Masitinib can slow the functional decline in ALS patients
Read More
Next-generation IL-10-based therapeutic with tumor-targeted delivery prevents CD8+ T-cell apoptosis
Read More
PK and PD of GSK-2292767A, a novel low-solubility inhaled phosphoinositide 3-kinase delta inhibitor
Read More
Selective CaMKII inhibition by gene therapy suppresses arrhythmias in CPVT models
Read More
Radioluminescent nanoparticle system allows for radiation-controlled release of chemotherapies
Read More
Alterity Therapeutics completes phase I study of PBT-434
Read More
FDA accepts IND application for CERC-802 for the treatment of MPI deficiency
Read More
Spring Bank receives FDA acceptance of IND application for intravenous SB-11285
Read More
Novel GLUT-4 translocation enhancers discoverd as potential therapeutic agents for diabetes mellitus
Read More
First-in-human results for two novel monovalent oral type 2 poliovirus vaccine candidates
Read More
CD19-BBz(86) anti-CD19 CAR T-cell therapy demonstrates safety and efficacy in phase I study
Read More
SHH signaling modulation as a promising new therapeutic strategy for ECO syndrome
Read More
BMP pathway blockade is a potential therapeutic approach for osteoarthritis
Read More
Roche divulges new MGL inhibitors
Read More
Allinky Biopharma identifies GTPase KRAS inhibitors
Read More
Medshine Discovery presents CXCR2 antagonists
Read More
Aurigene Discovery Technologies describes CD47 antagonists
Read More
Much bias, little binary: in sex differences in gene expression, "the whole genome is in the game"
Read More
Galecto Biotech identifies Gal-1 and Gal-3 inhibitors
Read More
4D presents new preclinical data on Live Biotherapeutic oncology programs
Read More
Microbiome metabolites modulate ALS
Read More
Biodesix and Immodulon Therapeutics collaborate on biomarker research for IMM-101
Read More
VBI advances phase I/IIa study of VBI-1901 for recurrent GBM into part B
Read More
Phase IIa study of AKST-4290 in refractory wet AMD meets primary endpoint
Read More
FDA clears Hepion's IND application to study CRV-431 for NASH
Read More
InterveXion reports interim data from phase II study of IXT-m200 for methamphetamine use disorder
Read More